Pfizer and Allergan scrap $160 bln "inversion" deal
April 06, 2016 at 06:50 AM EDT
April 6 (Reuters) - U.S. drugmaker Pfizer Inc and Ireland-based Allergan Plc formally announced that they were scrapping their $160 billion merger, marking a big win for President Barack Obama who has been pushing to curb tax-slashing "inversion" deals.
